Clinical Trial Update: Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CS-7017 in combination with FOLFIRI for metastatic colorectal cancer after failure of first-line therapy; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CS-7017
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Colorectal Cancer, Neoplasms, Colorectal | Phase 2 | Status: COMPLETED | Results posted: 2020-05-04